Favorable safety profile of Pradaxa (dabigatran etexilate) confirmed in
Complete Phase II results from the prospective GLORIATM-AF registry in dabig...
2018-03-23
文传商讯
Philip Morris International Releases Latest Scientific Update for Smoke
An In-Depth Look at How Good Clinical Practices Ensure Ethical Conduct of Hi...
2017-12-13
文传商讯
Boehringer Ingelheim expands collaboration with Sarah Cannon Research I
· Expanded partnership will evaluate SMAC mimetic alone and in comb...
2017-10-31
文传商讯
Wolters Kluwer Celebrates the 25th Anniversary of UpToDate with Launch
WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health announced today that ...
2017-10-11
文传商讯
Boehringer Ingelheim initiates Phase IIa study of compound acquired fro
Boehringer Ingelheim commences Phase II program of investigational drug cand...
2017-08-29
文传商讯
Boehringer Ingelheim and Sarah Cannon Research Institute launch strateg
Joint clinical development will study the combination of two checkpoint inhi...
2016-09-30
文传商讯
ESC Congress 2016 Late Breaking Science Registry Latest data on dabigat
First results from GLORIA™-AF Registry Program: Low incidences of stro...
2016-08-31
文传商讯
New analysis of INPULSIS trials demonstrates efficacy of OFEV (nintedan
For the first time the analysis shows that disease progression is similar in...
2016-06-27
文传商讯
PENTAX Medical Appoints Dr. Hudson Garrett, Global Chief Clinical Offic
TOKYO -- (BUSINESS WIRE) --PENTAX Medical, a division of HOYA Corporation, a...
2016-06-27
文传商讯
